Kirsten Harting

Kirsten Harting

Chief Tech/Sci/R&D Officer at ALZINOVA AB

Health Technology
Consumer Services
Commercial Services

Profile

Kirsten Harting is currently the Chief Medical Officer at Alzinova AB, SynAct Pharma AB, Tetra Pharm Technologies ApS, and Sandoz Group AG.
She previously worked as the Senior Director-Medical at CytoKi Pharma.
ApS.
Dr. Harting holds an MBA from Copenhagen Business School and a doctorate from the University of Copenhagen.

Kirsten Harting active positions

CompaniesPositionStart
ALZINOVA AB Chief Tech/Sci/R&D Officer 13/08/2023
SANDOZ GROUP AG Chief Tech/Sci/R&D Officer -
SYNACT PHARMA AB Chief Tech/Sci/R&D Officer 14/02/2024
Chief Tech/Sci/R&D Officer -
All active positions of Kirsten Harting

Former positions of Kirsten Harting

CompaniesPositionEnd
Chief Tech/Sci/R&D Officer -
See the detail of Kirsten Harting's experience

Training of Kirsten Harting

Copenhagen Business School Masters Business Admin
University of Copenhagen Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Kirsten Harting's experience

Connections

46

1st degree connections

7

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies3
ALZINOVA AB

Health Technology

SANDOZ GROUP AG

Health Technology

SYNACT PHARMA AB

Health Technology

Private companies2

Commercial Services

Health Technology

See company connections
  1. Stock Market
  2. Insiders
  3. Kirsten Harting